The government is planning to set up an expert panel for consultation on matters pertaining to the implementation of the drug price control order, including technicalities involved in pricing and new launches.

As per the Department of Pharmaceuticals (DoP), a multi-disciplinary committee of experts will have member secretary of National Pharmaceutical Pricing Authority (NPPA) as its convener.

It will also have representatives from Central Drugs Standard Control Organization (CDSCO), Department of Health Research/Indian Council of Medical Research and NIPER as members.

Besides, it will also give an opinion on technical related issues such as whether a drug is scheduled or non-scheduled on the basis of ingredients used in the formulation.

The technical issues will also include claims by pharma companies about novelty associated with indigenous research and development of their products, for granting exemption from the price control order for a period of 5 years.

Source: Times of India